ETHYLCELLULOSES
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9004573
- UNII
- 7Z8S9VYZ4B
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 6MG |
| Oral | Capsule, Enteric Coated Pellets | 18MG |
| Oral | Capsule, Extended Release | 134.25MG |
| Oral | Capsule, Sustained Action | 39.2MG |
| Oral | Capsule, Sustained Action, Hard Gelatin | 27.04MG |
| Oral | Granule, For Suspension | 85MG |
| Oral | Granule, For Suspension, Extended Release | |
| Oral | Powder | 29.85% |
| Oral | Powder, For Suspension | |
| Oral | Suspension, Sustained Action | |
| Oral | Tablet | 120.8MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 8.8MG |
| Oral | Tablet, Coated | 20MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 53.8MG |
| Oral | Tablet, Delayed Release | 3.61MG |
| Oral | Tablet, Extended Release | 100MG |
| Oral | Tablet, Film Coated | 83MG |
| Oral | Tablet, Orally Disintegrating | 35.28MG |
| Oral | Tablet, Sustained Action | 308.8MG |
| Oral | Tablet, Sustained Action, Coated | 15.15MG |
| Oral | Tablet, Sustained Action, Film Coated | 52.5MG |
| Oral-28 | Tablet | 1.05MG |
| Topical | Patch | |
| Transdermal | Film, Controlled Release | 80.4MG |
| Transdermal | Patch | |
| Transdermal | Patch, Electrically Controlled | 35MG |
| Vaginal | Tablet | 50MG |